Rohit Sahai, MD
Surgical Oncology · Chandler, AZNPI 1184827255
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (45.5%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 78.5% of it on its own, with 21 other manufacturers making up the rest. 2025 is the largest year on record at $3,164, 7.4 times the $430 reported in 2019.
Across 73 payments — averaging $75.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$4K
- Smith+Nephew$347
- Boston Scientific$173
- Merck$84
- Coloplast$75
- Johnson & Johnson$64
- plus $436 from 16 others
What the payments were for
- Travel & lodging$1,06919%
- Food & beverage$1,92135%
- Education$2,50046%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 16 | $4,311 |
| Smith+Nephew | 18 | $347 |
| Boston Scientific | 2 | $173 |
| Merck | 6 | $84 |
| Coloplast | 3 | $75 |
| Johnson & Johnson(2 entities) | 4 | $64 |
| Baxter Healthcare | 3 | $62 |
| Solventum Corporation | 2 | $50 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $48 |
| Abbott | 2 | $47 |
| Covidien LP | 3 | $43 |
| KCI USA, Inc. | 1 | $33 |
| Livanova USA, Inc. | 1 | $24 |
| Myriad Genetic Laboratories, Inc. | 1 | $18 |
| TELA Bio, Inc. | 1 | $16 |
| Pacira Pharmaceuticals Incorporated | 1 | $16 |
| Mimedx Group, Inc. | 1 | $15 |
| Intra-sana Laboratories | 1 | $15 |
| Innovation Technologies Inc | 1 | $13 |
| Acell, Inc. | 1 | $13 |
| Medtronic | 1 | $13 |
| Cook Medical LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,490 in reported general payments places this provider in the 80th percentile of 29 surgical oncology providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 30 | $487 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 68 | $393 |
| Tamsulosin Hcl | 11 | $74 |
| Levofloxacin | 11 | $63 |
Paid to pharmacies, not to this prescriber.
Other surgical oncology in Chandler
- David JacofskyPhoenix$11.3M
- Dipak RamkumarPhoenix$148K
- Mark GimbelGilbert$14K
- Zhi Ven FongPhoenix$7K
- Taylor RiallTucson$6K
- Sivakami MoorthyGlendale$5K
- Zeynep AydiPhoenix$4K
- Mohammad KhreissTucson$3K
- Epameinondas DogeasGilbert$3K
- Odette SolisPeoria$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.